Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-20 · accession 0001209191-23-056446 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-22 | 2023-11-20 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $9.69 | -3,287 | 217.4K | -1% | -$31.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-11-20 | S | D | 3,287 | $9.69 | 217,374 | D | — | — | (F2) The reporting person acquired 1,334 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2023. |